Additional Details

  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    UPMC Montefiore
    Pittsburgh PA. 15213
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Tufts Medical Center
    Boston MA. 02111
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of New Mexico
    Albuquerque NM. 87131
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Arizona Heart Rhythm Center
    Phoenix AZ. 85016
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    National Jewish Hospital
    Denver CO. 80206
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Onsite Clinical (Rowan Diagnostic)
    Salisbury NC. 28144
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Baylor Scott and White Research Institute
    Temple TX. 76508
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Velocity Clinical Research
    Spartanburg SC. 29303
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Weill Cornell Medicine
    New York NY. 10065
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Solace Clinical Research Summerlin
    Las Vegas NV. 89128
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Cincinnati Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine
    Cincinnati OH. 45219
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Stryde Research
    Carrollton TX. 75007
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Alabama
    Birmingham AL. 35294
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Nebraska Medical Center
    Omaha NE. 68198
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    NYU Langone Health
    New York NY. 10016
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    New Access Research and Medical Services
    Miami FL. 33186
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Brigham and Women's Hospital
    Boston MA. 02115
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Arizona
    Tucson AZ. 85748
    View Details
  • LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Yale New Haven Hospital
    New Haven CT. 06510
    View Details
  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    Temple University Hospital - Main Campus
    Philadelphia PA. 19140
    View Details